Inventor · disambiguated record
Finn Larsen
Also filed as: LARSEN FINN · LARSEN FINN THORVALD
10 granted patents·13 pending applications·37 citations·filing 1994–2025
83Inventor score
Top patents by PatentIndex Score
23 records- 0187US8192719B2Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compoundsLARSEN FINN·Filed 2007·Granted Jun 5, 2012·19 cites·25 claims
- 0274US9597350B2Composition comprising at least one alginate for use in treatment and/or prevention of overweightS-BIOTEK AF 15 MARTS 2006 1 APS·Filed 2015·Granted Mar 21, 2017·1 cites·20 claims
- 0372US12458680B2Reconstitutable teverelix-TFA compositionANTEV LTD·Filed 2023·Granted Nov 4, 2025·0 cites·10 claims
- 0472US9186409B2Solid pharmaceutical composition for neutralizing stomach acidLARSEN FINN·Filed 2011·Granted Nov 17, 2015·3 cites·4 claims
- 0572US2024366504A1Method of Preparing a Gelling Agent, the Gelling Agent Obtained Thereby, and the Use of Said Gelling AgentVIRAMAL LTD·Filed 2024·Application pending·0 cites
- 0668US12016953B2Method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agentVIRAMAL LTD·Filed 2019·Granted Jun 25, 2024·0 cites·8 claims
- 0764US11633453B2Reconstitutable teverelix-TFA compositionANTEV LTD·Filed 2019·Granted Apr 25, 2023·0 cites·12 claims
- 0859US2007087054A1Effervescent formulations of oxytocinARDANA BIOSCIENCE LTD·Filed 2006·Application pending·0 cites
- 0959US2007071818A1Effervescent formulations comprising apomorphineARDANA BIOSCIENCE LTD·Filed 2006·Application pending·0 cites
- 1058US11596601B2Mucoadhesive gel compositionVIRAMAL LTD·Filed 2019·Granted Mar 7, 2023·0 cites·19 claims
- 1156US2021338693A1Gel Compositions for Transdermal Delivery to Maximize Drug Concentrations in the Stratum Corneum and Serum and Methods of Use ThereofVIRAMAL LTD·Filed 2021·Application pending·0 cites
- 1254US2006034920A1Effervescent formulations of oxytocinLARSEN FINN·Filed 2003·Application pending·0 cites
- 1354US2006141032A1Effervescent formulations comprising apomorphineLARSEN FINN·Filed 2003·Application pending·0 cites
- 1449US2025352557A1Compositions for peritoneal drug delivery and methods of use thereofVIRAMAL LTD·Filed 2025·Application pending·0 cites
- 1546US9023828B2Composition comprising at least one alginate for use in treatment and/or prevention of overweightLARSEN FINN·Filed 2012·Granted May 5, 2015·0 cites·27 claims
- 1645US2020129583A1Composition for treating acute urinary retentionANTEV LTD·Filed 2018·Application pending·0 cites
- 1745US2018214506A1Combination administration of gnrh antagonistsANTEV LTD·Filed 2018·Application pending·0 cites
- 1845US2020000872A1A composition comprising at least one gnrh antagonistANTEV LTD·Filed 2018·Application pending·0 cites
- 1942US11446351B2Composition for treating one or more estrogen related diseasesLIFEARC·Filed 2019·Granted Sep 20, 2022·0 cites·4 claims
- 2040US2017196896A1Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereofVIRAMAL LTD·Filed 2017·Application pending·0 cites
- 2138US2020121589A1Compositions for drug delivery and methods of use thereofVIRAMAL LTD·Filed 2018·Application pending·0 cites
- 2237US5685489AShower headNORWEC A S·Filed 1994·Granted Nov 11, 1997·14 cites·5 claims
- 2337US2007218131A1Effervescent formulations comprising desmopressinARDANA BIOSCIENCE LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Finn Larsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →